OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Gastroenterology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	61
Cholangioscopy for biliary diseases	52
Clostridioides difficile infections; new treatments and future perspectives	51
Updates and innovations in therapeutic endoscopy	34
Editorial introductions	31
Mucosal defense: gastroduodenal injury and repair mechanisms	30
Editorial introductions	28
Small varices in chronic liver diseases	26
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	26
Hepatitis E virus: has anything changed?	24
Medical malpractice and gastrointestinal endoscopy	23
Using nutrition to help recovery from infections	22
Stomach and duodenum: what's current in 2023	22
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	22
Carnitine derivatives beyond fatigue: an update	21
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	19
Current and future microbiome-based therapies in inflammatory bowel disease	19
Editorial introductions	17
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	17
COVID-19 vaccine-induced liver injury	16
Considerations when starting patients on multiple biologics and small molecules	16
Prognostic modeling in biliary diseases	16
A brave new world: the gastrointestinal lab during and after a pandemic	15
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	15
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	14

Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	13
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	13
The gut virome in health and disease: new insights and associations	13
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	13
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	13
Implications of Paneth cell dysfunction on gastrointestinal health and disease	13
Clinical and translational markers of severity and prognosis in chronic pancreatitis	12
Gastric submucosal mass lesions	12
Gastroparesis: time for a paradigm change	11
Celiac disease and nonceliac enteropathies	11
Endoscopic management of colonic perforations	11
Tight junction proteins and biliary diseases	11
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems	11
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections	11
Nutritional aspects in patients with gastroparesis	10
Machine and deep learning in inflammatory bowel disease	10
Endoluminal bariatric and metabolic therapies: state-of-the-art	10
Role of albumin in the treatment of decompensated liver cirrhosis	10
Ergonomic wellness for the trainee in gastrointestinal endoscopy	10
Editorial: No organ is an island: the role of gut–organ axes in human health and disease	10
Managing the older adult with inflammatory bowel disease: is age just a number?	10
Bidirectional relationship between acute pancreatitis and pancreatic cancer	10
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	10
Intestinal proteases	9
Histological evaluation in biliary diseases	9
The rise of antibiotic resistance in Campylobacter	9
Endoscopic approaches to the management of hemorrhoids	9
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	9
Diagnosis and management of acute lower gastrointestinal bleeding	9
Advances in the evaluation and treatment of autoimmune hepatitis	8
Updates on therapeutic endoscopic ultrasound	8
Bile acid diarrhea – as bad as it gets?	8
Advances in endoscopic management of colonic diverticular bleeding	8
Editorial introductions	8
Updates in endoscopic management of ampullary and duodenal adenomas	8
Alterations in microbiome associated with acute pancreatitis	8
Artificial intelligence within the small bowel: are we lagging behind?	8
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	8
Editorial: Advances in hepatology: 2022	7
Pathophysiology updates: gastroduodenal injury and repair mechanisms	7
Editorial introductions	7
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	7
The status of endoscopic therapies for gastroesophageal reflux disease	7
Endoscopic approaches to small intestinal strictures	7
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	7
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	7
Celiac disease: clinical update	7
Diet and carcinogenesis of gastric cancer	7
The spectrum of diabetes in acute and chronic pancreatitis	7
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	7

Intestinal transplantation: an update	7
Editorial introductions	6
Editorial introductions	6
Endoscopic simulators: training the next generation	6
Neurological disorders and small bowel dysmotility	6
Editorial: The next-generation toolkit for exploring biliary diseases	6
The use of artificial intelligence in colonoscopic evaluations	6
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps	6
Editorial introductions	6
Bulking agents in gastrointestinal endoscopy: present applications and future advances	6
Update on extraesophageal manifestations of gastroesophageal reflux	6
Advances in colon-targeted drug technologies	6
Third space endoscopy: the future of treating gastrointestinal dysmotility	6
The bi-directional role of the gut–brain axis in inflammatory and other gastrointestinal diseases	5
Can SARS-CoV-2 be transmitted via faeces?	5
Small bowel Crohn's disease: optimal modality for diagnosis and monitoring	5
The vermiform cecal appendix, expendable or essential? A narrative review	5
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	5
Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?	5
Editorial: Stomach and duodenum: what is current in 2022?	5
Targeting osteopontin to treat primary sclerosing cholangitis	5
A ramble through the small bowel	5
Management of refractory inflammatory bowel disease	5
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	5
Immune markers of severe acute pancreatitis	5
Role of endoscopy on enteral feeding	5
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis	5
Gastroparesis	5
The prevention of gastric cancer by Helicobacter pylori eradication	5
Small bowel intussusception – aetiology & management	5
Editorial introduction	5
Retention of small bowel capsule endoscopy	5
Interpretation of serum pancreatic enzymes in pancreatic and nonpancreatic conditions	4
Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease	4
Editorial: The future of inflammatory bowel disease management	4
The evaluation of liver abnormalities in inflammatory bowel disease patients	4
Bile acids as metabolic regulators: an update	4
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities	4
Small intestinal bacterial overgrowth: current update	4
Editorial: Pathology in the small bowel – challenges, trials and tribulations	4
Population level screening for celiac disease: is now the time?	4
Macrophages in cholangiopathies	4
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management	4
The role of the microbiome in liver disease	4
Mast cell activation and nutritional disorders in patients with hypermobility	4
Imaging of the biliary tract	4
Road map to small bowel endoscopy quality indicators	4
Editorial: The fight against infectious diseases begins anew	3
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	3
The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma	3
Role of gut–kidney axis in renal diseases and IgA nephropathy	3
Update on pain management in acute pancreatitis	3
Selection of endoscopic resection technique for large colorectal lesion treatment	3
The use of ultrasound in colonic and perianal diseases	3
Noninvasive evaluation of fibrosis in adult biliary diseases	3
Gut microbiota and sepsis: from pathogenesis to novel treatments	3
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?	3
A practical guide to selecting and using new ulcerative colitis therapies	3
Clostridium difficile in inflammatory bowel disease	3
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors	3
Editorial introductions	3
Editorial introductions	3
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	3
Cellular senescence in the cholangiopathies	3
Colon polyps: updates in classification and management	3
A Practical guide to selecting and using new Crohn's disease therapies	3
Neuro-immune cell interactions in the regulation of intestinal immune homeostasis	3
Lichen planus esophagitis	3
Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract – a systematic review	3
Endobariatrics: well past infancy and maturing rapidly	3